Txnrd1 as a prognosticator for recurrence, metastasis and response to neoadjuvant chemotherapy and radiotherapy in breast cancer patients
Thioredoxin reductase 1 (Txnrd1) is known to have prognostic significance in a subset of breast cancer patients. Despite the pivotal role of Txnrd1 in regulating several cellular and physiological processes in cancer progression and metastasis, its clinical significance is largely unrecognized. Here...
Main Authors: | Raghavendra S. Patwardhan, Archita Rai, Deepak Sharma, Santosh K. Sandur, Sejal Patwardhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024030421 |
Similar Items
-
Oxidative Stress in Melanoma: Beneficial Antioxidant and Pro-Oxidant Therapeutic Strategies
by: Alyssa L. Becker, et al.
Published: (2023-06-01) -
Selenite selectively kills lung fibroblasts to treat bleomycin-induced pulmonary fibrosis
by: Jiun-Han Lin, et al.
Published: (2024-06-01) -
The over expression of thioredoxin during malignancies
by: Shahaboddin Shabani, et al.
Published: (2014-10-01) -
The over expression of thioredoxin during malignancies
by: Shahaboddin Shabani, et al.
Published: (2014-09-01) -
Interaction of recombinant form of NADPH-dependent thioredoxin reductase from rice with thioredoxin from two plant and bacterial sources
by: Hadiyeh Eslam Panah, et al.
Published: (2014-08-01)